NEWS & EVENTS

White Paper: Breakthroughs in Upper Gastrointestinal Tumours – Insights from ESMO 2024

Breakthroughs in Upper Gastrointestinal Tumours – Insights from ESMO 2024. White Paper based on late-breaking abstracts presented in Barcelona. Upper gastrointestinal (GI) tumours, including hepatocellular carcinoma (HCC), gastric cancer, and esophageal cancer, were a major focus at ESMO 2024, with sessions dedicated to advancing therapeutic strategies, improving patient outcomes, and addressing quality-of-life concerns. This white…
Read more

OXON’s RWE services and innovations at CTS 2024

OXON at CTS sharing a new method to boost trial and RWE study efficiency November 28-29, 2024 | Barcelona OXON will support CTS 2024 as an exhibitor, showcasing expanded services and new developments in RWE. OXON’s Epidemiology will be at the 9th Clinical Trial Summit in Barcelona to share how our Real-World Evidence (RWE)-driven clinical…
Read more

White Paper: Breakthroughs in Breast Cancer- Insights from ESMO 2024

Breakthroughs in Breast Cancer – Insights from ESMO 2024. White Paper based on late-breaking abstracts presented in Barcelona. Early-stage breast cancer, among the most frequently diagnosed cancers globally, was a key focus at this year’s ESMO conference, with sessions dedicated to advancing novel therapeutic strategies, improving personalized treatment approaches, and tackling survivorship challenges. “Breakthroughs in Breast…
Read more

White Paper: Breakthroughs in Melanoma – Insights from ESMO 2024

Breakthroughs in Melanoma – Insights from ESMO 2024. White Paper based on late-breaking abstracts presented in Barcelona. The advancements in melanoma therapies presented at this year’s ESMO conference mark a transformative shift in the treatment landscape, with Real-World Evidence (RWE) playing a pivotal role in personalizing patient care. By integrating real-world data with clinical trial…
Read more

New Study Published in JAMA Cardiology: ICDs vs. Amiodarone in Chagas Cardiomyopathy

Evaluating ICDs’ Role in Reducing Sudden Cardiac Death Among High-Risk Patients OXON Epidemiology’s latest study, recently featured in JAMA Cardiology, provides critical insights into the effectiveness of implantable cardioverter-defibrillators (ICDs) compared to amiodarone in reducing sudden cardiac death among patients with chronic Chagas cardiomyopathy. Known as the CHAGASICS Randomized Clinical Trial, the study enrolled 323…
Read more

FREE LIVE ONLINE WEBINAR SERIES ON RWE 2024-2025: Italy

‘Unlocking Success: Mastering RWE Studies in the Healthcare Landscape of Italy Next session of the Free Live Online Webinar Series on RWE hosted by OXON Date: Thursday, 24 October 2024 Time: 5pm CEST | 11am EDT | 8am PST Speaker: Prof. Carlo Giaquinto Professor of Paediatrics at the Department for Woman’s and Child’s Health of…
Read more

FREE LIVE ONLINE WEBINAR SERIES ON RWE 2024-2025: France

‘Unlocking Success: Mastering RWE Studies in the Healthcare Landscape of France Next session of the Free Live Online Webinar Series on RWE hosted by OXON Date: Thursday, 19 September 2024 Time: 5pm CEST | 11am EDT | 8am PST Speaker: Prof. Patrick Blin Pharmaco-Epi Senior Consultant, SNDS expert and Vice-president of the Ethics and Scientific…
Read more

OXON’s RWE services and innovations at ISPE Annual Meeting

OXON’s new RWE services and developments at ISPE Annual Meeting August 24-28, 2024 | Estrel Congress Center | Berlin, Germany OXON will be supporting ICPE 2024 as an exhibitor, showcasing expanded services and new developments in RWE. We are excited to announce that OXON’s Epidemiology team will be presenting and exhibiting at the ISPE 2024…
Read more

OXON RWE Alzheimer’s Research in 2024 Lancet Report

OXON Real-World Evidence Alzheimer’s Research in 2024 Lancet Report We are excited to announce that OXON’s Real-World Evidence (RWE) Alzheimer’s research has been prominently cited in the 2024 Lancet Commission on Dementia Report. This prestigious recognition underscores our commitment to advancing Alzheimer’s research and improving patient outcomes through evidence-based insights. Significant Contribution The Lancet Commission…
Read more

FREE LIVE ONLINE WEBINAR SERIES ON RWE 2024-2025: Japan

‘Unlocking Success: Mastering RWE Studies in the Healthcare Landscape of Japan Next session of the Free Live Online Webinar Series on RWE hosted by OXON Date: Thursday, 11 July 2024 Time: 5pm CEST | 11am EDT | 8am PST Speaker: Prof. Masao Iwagami Clinical Epidemiologist and Professor at the University of Tsukuba, and Honorary Assistant…
Read more